ReviewToxins2020
Bioactive Metabolites and Potential Mycotoxins Produced by
Review in Toxins, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 52 citations in OpenAlex.
- Acute neurotoxicity in a child following multi-component medicinal fungi supplementation: a case report.BMC complementary medicine and therapies · 2026Article
- Post-marketing surveillance of cordyceps products online: identifying falsified products and regulatory challenges.BMC complementary medicine and therapies · 2026Article
- Analysis of Amino Acid and Derivative Diversity and Antioxidant Capacity inJournal of fungi (Basel, Switzerland) · 2025Article
- Multi-omics insights into growth and fruiting body development in the entomopathogenic fungusIMA fungus · 2025Article
- Article
- Expanded Gene Regulatory Network Reveals Potential Light-Responsive Transcription Factors and Target Genes inInternational journal of molecular sciences · 2024Article
- Innovative application of CRISPR for eliminating Ustiloxin inLebensmittel-Wissenschaft + [i.e. und] Technologie. Food science + technology. Science + technologie alimentaire · 2024Article
- What are the 100 most cited fungal genera?Studies in mycology · 2024Article
- Trends and current food safety regulations and policies for functional foods and beverages containing botanicals.Journal of food and drug analysis · 2024Review
- Unique Bioactives from Zombie Fungus (Nutrients · 2023Review
- Three previously undescribed metabolites from Cordyceps cicadae JXCH-1, an entomopathogenic fungus.Natural products and bioprospecting · 2023Article
- A Review of the Potential Benefits of Herbal Medicines, Small Molecules of Natural Sources, and Supplements for Health Promotion in Lupus Conditions.Life (Basel, Switzerland) · 2023Review
- The Health and Clinical Benefits of Medicinal Fungi.Advances in biochemical engineering/biotechnology · 2023Article
- Systematic metabolomic studies identified adult adiposity biomarkers with acetylglycine associated with fat lossFrontiers in molecular biosciences · 2023Article
- Network Pharmacology-Based Exploration of the Therapeutic Mechanisms of Cordyceps cicadae in Renal Ischemia/Reperfusion.Annals of transplantation · 2022Article
- Metabolites and Their Bioactivities from the GenusMicroorganisms · 2022Review
- Metabolites and novel compounds with anti-microbial or antiaging activities from Cordyceps fumosorosea.AMB Express · 2022Article
- Article
- Improvement in the Blood Urea Nitrogen and Serum Creatinine Using New Cultivation ofEvidence-based complementary and alternative medicine : eCAM · 2022Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
Abstract
Ascomycete
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.